Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (302) GO Terms (7) Nucleotides (63) Proteins (7) Interactants (92) Wiki
XB-GENEPAGE-6492180

Papers associated with magainins



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

Optimization of the antimicrobial activity of magainin peptides by modification of charge., Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M., FEBS Lett. July 20, 2001; 501 (2-3): 146-50.

Embryotoxicity of magainin-2-amide and its enhancement by cyclodextrin, albumin, hydrogen peroxide and acidification., Mystkowska ET, Niemierko A, Komar A, Sawicki W., Hum Reprod. July 1, 2001; 16 (7): 1457-63.

Magainin-mediated disruption of stratum corneum lipid vesicles., Kaushik S, Krishnan A, Prausnitz MR, Ludovice PJ., Pharm Res. June 1, 2001; 18 (6): 894-6.

The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action., Unger T, Oren Z, Shai Y., Biochemistry. May 29, 2001; 40 (21): 6388-97.

Analysis of antimicrobial peptide interactions with hybrid bilayer membrane systems using surface plasmon resonance., Mozsolits H, Wirth HJ, Werkmeister J, Aguilar MI., Biochim Biophys Acta. May 2, 2001; 1512 (1): 64-76.

Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue., Hara T, Kodama H, Kondo M, Wakamatsu K, Takeda A, Tachi T, Matsuzaki K., Biopolymers. April 5, 2001; 58 (4): 437-46.

[Cloning and expression of a synthetic gene encoding magainin-melittin hybrid peptide in Escherichia coli and studies on its antibacterial activity]., Huang Y, Liu FP, Zhou TH, Zhu JM., Sheng Wu Gong Cheng Xue Bao. March 1, 2001; 17 (2): 207-10.

Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture., Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Scalise G., Antimicrob Agents Chemother. December 1, 2000; 44 (12): 3473-5.

Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures., Oh D, Shin SY, Lee S, Kang JH, Kim SD, Ryu PD, Hahm KS, Kim Y., Biochemistry. October 3, 2000; 39 (39): 11855-64.

Crystallization of antimicrobial pores in membranes: magainin and protegrin., Yang L, Weiss TM, Lehrer RI, Huang HW., Biophys J. October 1, 2000; 79 (4): 2002-9.

Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity., van't Hof W, Reijnders IM, Helmerhorst EJ, Walgreen-Weterings E, Simoons-Smit IM, Veerman EC, Amerongen AV., Antonie Van Leeuwenhoek. August 1, 2000; 78 (2): 163-9.

Cyclodextrin enhances spermicidal effects of magainin-2-amide., Wojcik C, Sawicki W, Marianowski P, Benchaib M, Czyba JC, Guerin JF., Contraception. August 1, 2000; 62 (2): 99-103.

Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria., Giacometti A, Cirioni O, Del Prete MS, Paggi AM, D'Errico MM, Scalise G., Peptides. August 1, 2000; 21 (8): 1155-60.

Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor., Kobayashi S, Takeshima K, Park CB, Kim SC, Matsuzaki K., Biochemistry. July 25, 2000; 39 (29): 8648-54.

Continuous measurement of rapid transbilayer movement of a pyrene-labeled phospholipid analogue., Müller P, Schiller S, Wieprecht T, Dathe M, Herrmann A., Chem Phys Lipids. June 1, 2000; 106 (1): 89-99.

Properties of cytotoxic peptide-formed ion channels., Kourie JI, Shorthouse AA., Am J Physiol Cell Physiol. June 1, 2000; 278 (6): C1063-87.

In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia., Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Fortuna M, Drenaggi D, Scalise G., Antimicrob Agents Chemother. June 1, 2000; 44 (6): 1716-9.

In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically., Giacometti A, Cirioni O, Barchiesi F, Del Prete MS, Fortuna M, Caselli F, Scalise G., Antimicrob Agents Chemother. June 1, 2000; 44 (6): 1694-6.

Three-dimensional solid-state NMR spectroscopy is essential for resolution of resonances from in-plane residues in uniformly (15)N-labeled helical membrane proteins in oriented lipid bilayers., Marassi FM, Ma C, Gesell JJ, Opella SJ., J Magn Reson. May 1, 2000; 144 (1): 156-61.

A solid-state NMR index of helical membrane protein structure and topology., Marassi FM, Opella SJ., J Magn Reson. May 1, 2000; 144 (1): 150-5.

Poor quality of oocytes from Xenopus laevis used in laboratory experiments: prevention by use of antiseptic surgical technique and antibiotic supplementation., Elsner HA, Hönck HH, Willmann F, Kreienkamp HJ, Iglauer F., Comp Med. April 1, 2000; 50 (2): 206-11.

Membrane binding and pore formation of the antibacterial peptide PGLa: thermodynamic and mechanistic aspects., Wieprecht T, Apostolov O, Beyermann M, Seelig J., Biochemistry. January 18, 2000; 39 (2): 442-52.

Molecular dynamics simulation studies of lipid bilayer systems., Pasenkiewicz-Gierula M, Murzyn K, Róg T, Czaplewski C., Acta Biochim Pol. January 1, 2000; 47 (3): 601-11.

Grazing incidence X-ray diffraction of highly aligned phospholipid membranes containing the antimicrobial peptide magainin 2., Münster C, Lu J, Bechinger B, Salditt T., Eur Biophys J. January 1, 2000; 28 (8): 683-8.

The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy., Bechinger B., Biochim Biophys Acta. December 15, 1999; 1462 (1-2): 157-83.

Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes., Matsuzaki K., Biochim Biophys Acta. December 15, 1999; 1462 (1-2): 1-10.

In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics., Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G., Eur J Clin Microbiol Infect Dis. November 1, 1999; 18 (11): 827-9.

In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa., Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G., J Antimicrob Chemother. November 1, 1999; 44 (5): 641-5.

Antiviral effects of synthetic membrane-active peptides on herpes simplex virus, type 1., Egal M, Conrad M, MacDonald DL, Maloy WL, Motley M, Genco CA., Int J Antimicrob Agents. September 1, 1999; 13 (1): 57-60.

In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates., Giacometti A, Cirioni O, Barchiesi F, Caselli F, Scalise G., J Antimicrob Chemother. September 1, 1999; 44 (3): 403-6.

Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure., Wieprecht T, Beyermann M, Seelig J., Biochemistry. August 10, 1999; 38 (32): 10377-87.

In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi., Giacometti A, Cirioni O, Ancarani F, Del Prete MS, Fortuna M, Scalise G., Antimicrob Agents Chemother. August 1, 1999; 43 (8): 2093-6.

Not only the nature of peptide but also the characteristics of cell membrane determine the antimicrobial mechanism of a peptide., Liang JF, Kim SC., J Pept Res. May 1, 1999; 53 (5): 518-22.

Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria., Matsuzaki K, Sugishita K, Miyajima K., FEBS Lett. April 23, 1999; 449 (2-3): 221-4.

A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides., Helmerhorst EJ, Reijnders IM, van 't Hof W, Veerman EC, Nieuw Amerongen AV., FEBS Lett. April 23, 1999; 449 (2-3): 105-10.

Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp., Devine DA, Marsh PD, Percival RS, Rangarajan M, Curtis MA., Microbiology (Reading). April 1, 1999; 145 ( Pt 4) 965-971.

Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli., Vorland LH, Ulvatne H, Rekdal O, Svendsen JS., Scand J Infect Dis. January 1, 1999; 31 (5): 467-73.

Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides., Shin SY, Kang JH, Hahm KS., J Pept Res. January 1, 1999; 53 (1): 82-90.

Biological activities of 1,1,6-trisubstituted indanes: beyond magainin 2., Numao N, Hirota Y, Iwahori A, Kidokoro S, Sasatsu M, Kondo I, Itoh S, Itoh E, Katoh T, Shimozono N, Yamazaki A, Takao K, Kobayashi S., Biol Pharm Bull. January 1, 1999; 22 (1): 73-6.

Membrane helix orientation from linear dichroism of infrared attenuated total reflection spectra., Bechinger B, Ruysschaert JM, Goormaghtigh E., Biophys J. January 1, 1999; 76 (1 Pt 1): 552-63.

Antimicrobial peptides of the brevinin-2 family isolated from gastric tissue of the frog, Rana esculenta., Wang Y, Knoop FC, Remy-Jouet I, Delarue C, Vaudry H, Conlon JM., Biochem Biophys Res Commun. December 30, 1998; 253 (3): 600-3.

In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria., Giacometti A, Cirioni O, Greganti G, Quarta M, Scalise G., Antimicrob Agents Chemother. December 1, 1998; 42 (12): 3320-4.

The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides., Banemann A, Deppisch H, Gross R., Infect Immun. December 1, 1998; 66 (12): 5607-12.

Magainins as paradigm for the mode of action of pore forming polypeptides., Matsuzaki K., Biochim Biophys Acta. November 10, 1998; 1376 (3): 391-400.

Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa., Matsuzaki K, Mitani Y, Akada KY, Murase O, Yoneyama S, Zasloff M, Miyajima K., Biochemistry. October 27, 1998; 37 (43): 15144-53.

In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii., Cirioni O, Giacometti A, Barchiesi F, Scalise G., J Antimicrob Chemother. October 1, 1998; 42 (4): 445-51.

Synergistic antibacterial action of heat in combination with nisin and magainin II amide., Ueckert JE, ter Steeg PF, Coote PJ., J Appl Microbiol. September 1, 1998; 85 (3): 487-94.

Relationship of membrane curvature to the formation of pores by magainin 2., Matsuzaki K, Sugishita K, Ishibe N, Ueha M, Nakata S, Miyajima K, Epand RM., Biochemistry. August 25, 1998; 37 (34): 11856-63.

In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii., Cirioni O, Giacometti A, Barchiesi F, Scalise G., J Antimicrob Chemother. August 1, 1998; 42 (2): 141-5.

Release of aqueous contents from phospholipid vesicles induced by cecropin A (1-8)-magainin 2 (1-12) hybrid and its analogues., Kang JH, Shin SY, Jang SY, Lee MK, Hahm KS., J Pept Res. July 1, 1998; 52 (1): 45-50.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 ???pagination.result.next???